Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Review ArticleContinuing Education

Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings

Giacomo Pirovano, Sheryl Roberts, Susanne Kossatz and Thomas Reiner
Journal of Nuclear Medicine October 2020, 61 (10) 1419-1427; DOI: https://doi.org/10.2967/jnumed.119.238279
Giacomo Pirovano
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheryl Roberts
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanne Kossatz
2Department of Nuclear Medicine, University Hospital Klinikum Rechts der Isar, Technical University Munich, Munich, Germany
3Central Institute for Translational Cancer Research, Technical University of Munich, Munich, Germany
4Department of Chemistry, Technical University of Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Reiner
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
5Department of Radiology, Weill Cornell Medical College, New York, New York; and
6Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Schematic representation of various optical imaging modalities discussed in this review. Different modalities are represented as different boats, each with its individual pros and cons and its specific utility. (Printed with permission of Memorial Sloan Kettering Cancer Center.)

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Fluorescence disease imaging. (A) Incident laser light can excite electron to E1; relaxation of acquired excited state emits light known as fluorescence. Ein is the incident photon energy, v is its frequency, and h is the Plank constant. (B) One potential application for fluorescence molecules targeting tumors is margin delineation of surface lesions, such as in oropharyngeal cancer. (C) Fluorescent dyes have broad application in laboratory settings, such as in flow cytometry sorting or fluorescent microscopy. (D) Example of use of PARPi-FL, a fluorescent molecule targeting poly(adenosine diphosphate ribose) polymerase 1, for tumor detection in clinic. Ex/Em = excitation/emission. (Adapted with permission of (22).)

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Bioluminescence method for disease imaging. (A) Bioluminescence emission occurs on oxidation of substrate (luciferin) by enzyme (luciferase), in some cases requiring cofactors such as adenosine triphosphate and magnesium. (B) In BLI animal models, transplanted cells or genetically modified tissues express luciferin, whereas luciferase is delivered systemically to induce bioluminescence. (C) In small animals, bioluminescence detection usually occurs using charge-coupled-device cameras, which are suitable for low-light detection. NIR = near infrared.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Optoacoustic methods for cancer detection. (A) Excitation from light absorption causes absorber to undergo radiative relaxation, which generates local heating. Thermal relaxation generates pressure waves and, in turn, thermoelastic expansion, known as photoacoustic effect. (B) Example of optoacoustic imaging setup (multispectral optoacoustic tomography, or MSOT), which surrounds tissue of interest with ring laser and ultrasound transducer in 270° array. MSOT has tunable laser (680–900 nm) and allows for multispectral unmixing. (C) Representative MSOT images after multispectral unmixing before (top) and after (bottom) intravenous injection of NIR dye (green) and overlaid with optoacoustic background (900 nm). Ein is the incident photon energy, ER is the relaxation energy, ET1 and ET2 represent thermal relaxation energy, and Ed is the difference of relaxation energy. v and v′ refer to the photon frequency, and h represents the Plank constant. a.u. = arbitrary units; i.v. = intravenous; US = ultrasound. (Adapted with permission of (41,90).)

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Cerenkov luminescence light for disease detection. (A) Left: Charged particle (red dot) traveling more quickly than light in medium polarizes medium. Right: As medium returns to ground state, blue-weighted light is emitted in forward direction. (B) Cerenkov light is emitted (blue cone and arrow) by medium in which charged particle travels. Radionuclides that emit β-particles with energies greater than Cerenkov threshold (261 keV in water) result in CL. (C) Left: White-light photograph from left axilla, overlaid with significant CL signal. Right: This signal colocalized with PET/CT finding. CCD = charge-coupled device. (Adapted with permission of (68,83).)

Tables

  • Figures
    • View popup
    TABLE 1

    Comparison of Optical Imaging Modalities

    ParameterFluorescenceBioluminescenceOptoacousticCL
    PrincipleAbsorption of light excites status of dye and its relaxation emits lightOxidation of substrate by enzyme emits lightLight is absorbed and causes molecular vibrations that emit sound wavesCharged particles travel quickly through medium and emit light
    AdvantageEasy to perform; large variety of dyesNo incident radiation needed; no backgroundSafeSafe and informative
    DisadvantageNeeds excitation sourceIs not yet clinicalNeeds complex image reconstructionNeeds radioactive preinjection
    Translatable?YesNot currentlyYesYes
    Ease to implementMediumMediumMediumDifficult
    Ease to useEasyMediumMediumMedium
    Ease to detectEasyEasyMediumMedium
    Detectable rangeVisible spectrum and NIR470–750 nm400–800 nm (RSOM), 680–980 nm (MSOT)Ultraviolet-to-visible spectrum
    Preclinical applicationsIn vitro and in vivo molecular imagingIn vitro and in vivo molecular imagingIn vivo tumor and vasculature imagingIn vivo tumor imaging
    Potential clinical applicationsScreening, diagnostic, intraoperativeStem cell or chimeric antigen receptor T-cell trackingMuscular dystrophy, vasculature, cancer imagingPositive lymph nodes and cancer detection
    CostLowLowMediumHigh
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (10)
Journal of Nuclear Medicine
Vol. 61, Issue 10
October 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
Giacomo Pirovano, Sheryl Roberts, Susanne Kossatz, Thomas Reiner
Journal of Nuclear Medicine Oct 2020, 61 (10) 1419-1427; DOI: 10.2967/jnumed.119.238279

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings
Giacomo Pirovano, Sheryl Roberts, Susanne Kossatz, Thomas Reiner
Journal of Nuclear Medicine Oct 2020, 61 (10) 1419-1427; DOI: 10.2967/jnumed.119.238279
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • FLUORESCENCE IMAGING
    • Bioluminescence Imaging (BLI)
    • OPTOACOUSTIC IMAGING
    • CL IMAGING
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • A Phase I Study of a PARP1-targeted Topical Fluorophore for the Detection of Oral Cancer
  • Google Scholar

More in this TOC Section

  • Approaches to Imaging Immune Activation Using PET
  • Large Language Models and Large Multimodal Models in Medical Imaging: A Primer for Physicians
  • Precision Oncology in Melanoma: Changing Practices
Show more Continuing Education

Similar Articles

Keywords

  • imaging
  • optical modalities
  • cancer
SNMMI

© 2025 SNMMI

Powered by HighWire